• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Considerations for the Development and Manufacturing of Biosimilars [Presentation]

Article

This content is provided by Amgen.

Divided into 3 sections, this presentation provides insight into the complexities of developing and manufacturing biologics and discusses considerations for the development of biosimilars.

Please click the image below to view the presentation.

Related Videos
1 expert is featured in this series.
5 experts are featured in this series.
5 experts are featured in this series
1 expert is featured in this series.
1 expert is featured in this series.
Firas El Chaer, MD, smiling during a video interview
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.